Theravance, Inc. · South San Francisco, CA United States (NASDAQ: THRX)
| 901 Gateway Blvd. | Phone: 650-808-6000 |
| South San Francisco, CA | Fax: 650-827-8690 |
| 94080 | |
| United States | 
Map This Company |
Theravance, Inc. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Theravance figures there's no sense in re-inventing the wheel. The biotechnology firm takes aim at already proven biological targets, taking advantage of previous years of research to create more effective, next-generation treatments. Its development programs focus on respiratory disease, bacterial infections, and gastrointestinal and neurological conditions. Its sole marketed product, VIBATIV (an injectable antibiotic approved to treat skin infections and hospital-acquired pneumonia) was successfully developed and commercialized with partner
Theravance, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: THRX Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 193 |
Executives
74 executives listed for Theravance, Inc.'s South San Francisco, CA location.
| Chairman and CEO | Rick Winningham | |
|---|---|---|
| SVP and CFO | Michael Aguiar | |
| SVP and Chief Commercial Officer | Leonard Blum |